Induction Therapy of Tislelizumab Combined with Cisplatin and 5-Fluorouracil and Subsequent Conversion Surgery in Patients with Unresectable Advanced Esophageal Squamous Cell Carcinoma: A Phase 2, Single Center Study

Tongpeng Xu(Jiangsu Province Hospital), Yue Zhou(Sichuan University), Ling Zhu(Northwest A&F University), Fei Pang(Capital Medical University), Yongqian Shu(Jiangsu Province Hospital), Jian’an Bai(Nanjing Medical University), Xiaofeng Chen(Ningbo University), Wei Wang(First Affiliated Hospital of Wannan Medical College), Fang Li(Jiangsu Province Hospital), Ting Wang(Jilin University), Shuhui Wang(Capital Medical University), Junling Zhang, Meizhen Hu(Chinese Academy of Tropical Agricultural Sciences), Kun Zhao(Vanderbilt University Medical Center), Shusheng Zhu(Yunnan Agricultural University), Chenhui Zhao(Nanchang University), Chongqi Sun(Nanjing Medical University)
Annals of Surgical Oncology
August 23, 2024
Cited by 8


Related Papers